By Kat Greene ( May 2, 2017, 10:52 PM EDT) -- A New York appeals court revived New York University's 2013 lawsuit against Pfizer Inc. over royalties for cancer medicine Xalkori, which the school claimed it was instrumental in developing, finding in a split decision Tuesday that a contract fight between NYU and a drug research company couldn't be resolved without more evidence....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.